Fluconazole is Primarily Excreted by the Kidneys
Fluconazole elimination is almost entirely renal, with approximately 80% of the administered dose excreted unchanged in the urine 1. This is a critical pharmacokinetic characteristic that directly impacts dosing decisions in patients with renal impairment.
Key Pharmacokinetic Facts
The renal excretion profile of fluconazole is well-established:
- 80% excreted unchanged in urine as the active drug 1
- Only about 11% is excreted as metabolites 1
- Urine concentrations reach 10-20 times the plasma concentrations 2
- The drug is metabolically stable with minimal hepatic metabolism 3
This predominantly renal elimination pathway is why fluconazole achieves such high urinary concentrations, making it the preferred treatment option for symptomatic cystitis 2.
Clinical Implications for Dosing
Renal Impairment
Dose reduction is mandatory in patients with creatinine clearance <50 mL/minute 2, 1. The FDA label provides specific guidance:
- CrCl >50 mL/min: 100% of standard dose
- CrCl ≤50 mL/min (no dialysis): 50% of standard dose
- Hemodialysis patients: 100% of recommended dose after each hemodialysis session 1
The inverse relationship between elimination half-life and creatinine clearance is well-documented 1. Failure to adjust doses in renal dysfunction can lead to drug accumulation and increased toxicity risk.
Hepatic Impairment
In contrast to the significant renal considerations, fluconazole does NOT require routine dose adjustment for hepatic dysfunction 2. This distinguishes it from voriconazole, which is the only triazole requiring dosage reduction for mild to moderate hepatic impairment 2.
Common Pitfall to Avoid
Do not confuse fluconazole with the echinocandins (caspofungin, micafungin, anidulafungin), which undergo nonenzymatic degradation and require NO renal dose adjustment 2. Echinocandins also do not achieve therapeutic concentrations in urine, making them inappropriate for urinary tract infections 2.
Practical Monitoring
In elderly patients, who characteristically have reduced renal function, monitor renal function and adjust doses based on creatinine clearance 1. The pharmacokinetic alterations observed in elderly patients are primarily attributable to decreased kidney function rather than age itself 1.
For patients on dialysis, fluconazole is significantly cleared: approximately 50% removal during a 3-hour hemodialysis session 1, and up to 72% during a 6-hour SLED-f session 4. Always administer supplemental dosing post-dialysis 1.